TGFB1 and Ewing sarcoma: Previous studies have shown that TGFβRII is a major down regulated target of EWS-FLI1 oncoprotein [27] and introduction of normal TGFβRII into Ewing’s sarcoma cell lines restores TGFβ sensitivity and blocks tumorigenicity.